Evelo Biosciences, Inc. (EVLO) earnings
Quarterly and annual EVLO reports and results, each read against the price at its own news timestamp. Back to the EVLO overview →
1 measured EVLO earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Evelo Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.53% | -7.27% |
Keep exploring
More EVLO: analyst actions → · SEC filings → · EVLO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIOFORCE NANOSCIENCES HLD (BFNH) | 30 | +0.30% | 50% |
| Aridis Pharmaceuticals Inc. (ARDS) | 28 | 0.00% | 48% |
| Nu-Med Plus Inc. Com (NUMD) | 28 | 0.00% | 41% |
| RESPIRERX PHARMA INC (RSPI) | 28 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.